MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.semarthrit.2021.12.007

Медицинская библиотека · Seminars in arthritis and rheumatism · 2021

Impact of the number of comorbidities on the outcome measures and on the retention rate of the first anti-TNF in patients with Ankylosing Spondylitis. Two-year follow-up in REGISPONSER-AS.

Puche-Larrubia M Ángeles, Ladehesa-Pineda Lourdes, Gómez-García Ignacio, Font-Ugalde Pilar, Escudero-Contreras Alejandro, Collantes-Estévez Eduardo, López-Medina Clementina, REGISPONSER study group

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

OBJECTIVES

To evaluate the impact of the number of comorbidities on the outcome measures after two years of follow-up in patients with Ankylosing Spondylitis (AS) and to determine whether the number of comorbidities influences the retention rate of the first anti-TNF.

METHODS

This was an observational and prospective study conducted during 2 years of follow-up in the REGISPONSER-AS registry. The patients were divided into three groups according to the number of comorbidities at baseline (0, 1 or ≥2). Linear regression models adjusted for disease duration, age, sex and smoking were constructed to evaluate the association between the number of comorbidities and the Patient Reported Outcomes (PRO) scores. The impact of the number of comorbidities on PROs over two years of follow-up was evaluated using mixed models for repeated measures adjusted for disease duration, age, sex and smoking. Finally, the retention rate of the first anti-TNF antibody across the three groups was evaluated using a log-rank test.

RESULTS

Patients with two or more comorbidities showed higher scores at baseline and during the two years of follow-up for the Global VAS, BASDAI, ASDAS, and BASFI and worse scores for the physical component of the SF12. A higher probability of discontinuation of the first anti-TNF was found in patients with 2 or more comorbidities compared with the patients in the other groups (38.2% vs. 26.6% vs. 25.4% for ≥2 comorbidities, 0 and 1 comorbidity, respectively), although these differences were not significant (log-rank test: p-value = 0.180).

CONCLUSION

In patients with AS, the presence of 2 or more comorbidities was associated with worse scores on the outcome measures test after two years of follow-up and a greater tendency of discontinuation for the first anti-TNF.

Для цитирования: Puche-Larrubia M Ángeles, Ladehesa-Pineda Lourdes, Gómez-García Ignacio, Font-Ugalde Pilar, Escudero-Contreras Alejandro, Collantes-Estévez Eduardo, López-Medina Clementina, REGISPONSER study group. Impact of the number of comorbidities on the outcome measures and on the retention rate of the first anti-TNF in patients with Ankylosing Spondylitis. Two-year follow-up in REGISPONSER-AS.. Seminars in arthritis and rheumatism. 2021. DOI: 10.1016/j.semarthrit.2021.12.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.